Novo Nordisk CEO Mike Doustdar says Ozempic maker looking for deals
Nordisk is looking for deals more than ever, the Danish drugmaker's CEO said Wednesday in an interview with CNBC. “If…
Biotechnology and pharmaceuticals
Pfizer (PFE) earnings in the first quarter of 2026
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. See Press | Corbis News…
Eli Lilly (LLY) earnings in the first quarter of 2026
Eli Lilly on Thursday reported first-quarter earnings and revenue that beat estimates and raised its full-year sales outlook by $2…
The growing LPG-1 market
When Branneisha Cooper began receiving the GLP-1 injection in Mounjaro in late 2022, she heard online that she could experience…
Trump picks Nicole Saphier as surgeon general after removing Casey Means
Dr. Nicole Saphier appears on FOX Nation's “Love Mom The Live Show” at Fox News Channel Studios on April 3,…
UnitedHealth Group (UNH) earnings in the first quarter of 2026
A UnitedHealthcare sign is displayed on its office building in Minnetonka, Minnesota, U.S., on Dec. 11, 2025. Tim Evans |…
Intellia's Crispr Gene Editing Treatment Succeeds in Phase 3 Trial
Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, United States. Spencer Scholarship | Universal Image Group | fake images…
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
Regeneron signs drug pricing deal with Trump, will offer free hearing loss therapy
Regeneron He agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump,…
Regeneron weighs overseas pricing of gene therapy for rare hearing loss
Regeneron Pharmaceuticals will make its recently approved gene therapy for a rare genetic form of hearing loss available for free…